Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP925601.RALX3_1awuXTD1dgTkO34Yomt7GAgrD0kk_bR0IVnLkH8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925601.RALX3_1awuXTD1dgTkO34Yomt7GAgrD0kk_bR0IVnLkH8130_assertion type Assertion NP925601.RALX3_1awuXTD1dgTkO34Yomt7GAgrD0kk_bR0IVnLkH8130_head.
- NP925601.RALX3_1awuXTD1dgTkO34Yomt7GAgrD0kk_bR0IVnLkH8130_assertion description "[Our data indicates that AChEI treatment down-regulates IL-1, IL-6 and TNF, and up-regulates the expression and production of IL-4 in PBMC in AD patients, and that AChEI leads to the remodelling of the cytokine network, probably acting on the lymphocytic cholinergic system.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925601.RALX3_1awuXTD1dgTkO34Yomt7GAgrD0kk_bR0IVnLkH8130_provenance.
- NP925601.RALX3_1awuXTD1dgTkO34Yomt7GAgrD0kk_bR0IVnLkH8130_assertion evidence source_evidence_literature NP925601.RALX3_1awuXTD1dgTkO34Yomt7GAgrD0kk_bR0IVnLkH8130_provenance.
- NP925601.RALX3_1awuXTD1dgTkO34Yomt7GAgrD0kk_bR0IVnLkH8130_assertion SIO_000772 14975597 NP925601.RALX3_1awuXTD1dgTkO34Yomt7GAgrD0kk_bR0IVnLkH8130_provenance.
- NP925601.RALX3_1awuXTD1dgTkO34Yomt7GAgrD0kk_bR0IVnLkH8130_assertion wasDerivedFrom befree-20140225 NP925601.RALX3_1awuXTD1dgTkO34Yomt7GAgrD0kk_bR0IVnLkH8130_provenance.
- NP925601.RALX3_1awuXTD1dgTkO34Yomt7GAgrD0kk_bR0IVnLkH8130_assertion wasGeneratedBy ECO_0000203 NP925601.RALX3_1awuXTD1dgTkO34Yomt7GAgrD0kk_bR0IVnLkH8130_provenance.